ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Ohio » Clinical Cardiac Electrophysiology

Top Clinical Cardiac Electrophysiology Prescribers in Ohio

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SALEEM AHMAD M.D.

Clinical Cardiac Electrophysiology

6,864

$484K

613
561 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 23%

$70
Average prescription price

Avg: $71

VINCENT GUINN MD

Clinical Cardiac Electrophysiology

5,622

$260K

518
418 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $71

MARK O'CONNOR MD

Clinical Cardiac Electrophysiology

5,422

$255K

464
376 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $71

SHELDON BROWNSTEIN M.D.

Clinical Cardiac Electrophysiology

4,823

$337K

474
361 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 23%

$70
Average prescription price

Avg: $71

MICHAEL MARKEL M.D.

Clinical Cardiac Electrophysiology

4,554

$287K

465
407 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $71

NASSER SMILEY MD

Clinical Cardiac Electrophysiology

4,240

$242K

1043
914 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $71

JOHN WILSON M.D.

Clinical Cardiac Electrophysiology

3,573

$133K

528
477 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 23%

$37
Average prescription price

Avg: $71

GREGORY BONAVITA M.D.

Clinical Cardiac Electrophysiology

3,518

$261K

482
445 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 23%

$74
Average prescription price

Avg: $71

SRINIVASA SATTI M.D.

Clinical Cardiac Electrophysiology

3,402

$242K

499
435 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 23%

$71
Average prescription price

Avg: $71

IHSAN HAQUE MD

Clinical Cardiac Electrophysiology

3,370

$216K

323
280 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $71

SANDEEP GUPTA M.D.

Clinical Cardiac Electrophysiology

3,166

$204K

454
383 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $71

MARK RICHARDS M.D.

Clinical Cardiac Electrophysiology

2,998

$198K

810
717 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 23%

$66
Average prescription price

Avg: $71

FIRAS HAMDAN M.D.

Clinical Cardiac Electrophysiology

2,826

$202K

437
376 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 23%

$72
Average prescription price

Avg: $71

CHOUDHARY RAYANI MD

Clinical Cardiac Electrophysiology

2,810

$208K

387
294 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 23%

$74
Average prescription price

Avg: $71

KEVIN KRAVITZ MD

Clinical Cardiac Electrophysiology

2,769

$200K

321
290 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 23%

$72
Average prescription price

Avg: $71

IRA FRIEDLANDER M.D.

Clinical Cardiac Electrophysiology

2,712

$258K

413
382 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 23%

$95
Average prescription price

Avg: $71

DANIEL BUERKEL MD

Clinical Cardiac Electrophysiology

2,699

$160K

745
653 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $71

MARTIN WISEMAN MD

Clinical Cardiac Electrophysiology

2,465

$136K

356
340 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $71

BARTOLOMEO GIANNATTASIO MD

Clinical Cardiac Electrophysiology

2,457

$136K

335
300 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $71

SAMEH KHOUZAM MD

Clinical Cardiac Electrophysiology

2,446

$219K

274
241 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 23%

$89
Average prescription price

Avg: $71

JOHAN AASBO D.O.

Clinical Cardiac Electrophysiology

2,438

$165K

736
639 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 23%

$68
Average prescription price

Avg: $71

MICHAEL PELINI MD

Clinical Cardiac Electrophysiology

2,316

$158K

345
311 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 23%

$68
Average prescription price

Avg: $71

JASON SMITH MD

Clinical Cardiac Electrophysiology

2,121

$122K

301
277 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $71

K BAIG MD

Clinical Cardiac Electrophysiology

2,076

$183K

314
297 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 23%

$88
Average prescription price

Avg: $71

KAMALA TAMIRISA MD

Clinical Cardiac Electrophysiology

2,006

$106K

635
554 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $71

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank